Drug class
Non-Nitrate Coronary Vasodilators
"Non-nitrate coronary vasodilators" is a descriptive, heterogeneous pharmacological category rather than a single standardized regulatory drug class. Read more about Non-Nitrate Coronary Vasodilators
29 drugs in this class 23 manufacturers
Drugs in Non-Nitrate Coronary Vasodilators
LEXISCAN (regadenoson)
DIPYRIDAMOLE
ASPIRIN-DIPYRIDAMOLE ER (aspirin/dipyridamole)
ASPIRIN-DIPYRIDAMOLE ER (aspirin/dipyridamole)
ASPIRIN-DIPYRIDAMOLE ER (aspirin/dipyridamole)
ASPIRIN-DIPYRIDAMOLE (aspirin/dipyridamole)
ASPIRIN-DIPYRIDAMOLE (aspirin/dipyridamole)
REGADENOSON
"Non-nitrate coronary vasodilators" is a descriptive, heterogeneous pharmacological category rather than a single standardized regulatory drug class.
These agents promote coronary artery dilation and enhance myocardial perfusion through mechanisms independent of nitric oxide donation, primarily including calcium channel blockers like diltiazem and verapamil, adenosine receptor agonists such as dipyridamole, and direct arteriolar relaxants.
By reducing coronary vascular resistance and lowering myocardial wall tension or oxygen demand, they counteract ischemia and suppress vascular spasm.
Clinically, medications in this grouping are predominantly utilized in the prevention and management of chronic stable angina, vasospastic (Prinzmetal) angina, and as pharmacological stress agents during myocardial perfusion imaging.
-
nih.gov
"Non-nitrate coronary vasodilators" is a descriptive, heterogeneous pharmacological category rather than a single standardized regulatory drug class These agents promote coronary artery dilation and enhance myocardial perfusion through mechanisms independent of nitric oxide donation, primarily including calcium channel blockers like diltiazem and verapamil, adenosine receptor agonists such as dipyridamole, and direct arteriolar relaxants
-
fda.gov
These agents promote coronary artery dilation and enhance myocardial perfusion through mechanisms independent of nitric oxide donation, primarily including calcium channel blockers like diltiazem and verapamil, adenosine receptor agonists such as dipyridamole, and direct arteriolar relaxants By reducing coronary vascular resistance and lowering myocardial wall tension or oxygen demand, they counteract ischemia and suppress vascular spasm
-
cardionerds.com
These agents promote coronary artery dilation and enhance myocardial perfusion through mechanisms independent of nitric oxide donation, primarily including calcium channel blockers like diltiazem and verapamil, adenosine receptor agonists such as dipyridamole, and direct arteriolar relaxants By reducing coronary vascular resistance and lowering myocardial wall tension or oxygen demand, they counteract ischemia and suppress vascular spasm Clinically, medications in this grouping are predominantly...
-
nih.gov
Clinically, medications in this grouping are predominantly utilized in the prevention and management of chronic stable angina, vasospastic (Prinzmetal) angina, and as pharmacological stress agents during myocardial perfusion imaging
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.